CHELSEA THERAPEUTICS INTERNATIONAL, LTD.
CIK 0001333763
Revenue (TTM)
—
Q1 May 2014
Net Income (TTM)
−$19.17M
+48.3% YoY
Q1 May 2014
EPS Diluted (TTM)
—
Q1 May 2014
Gross Margin
—
Q1 May 2014
Operating Margin
—
Q1 May 2014
Net Margin
—
Q1 May 2014
Free Cash Flow (TTM)
−$36.93M
Q1 May 2014
Cash
$37.09M
Q1 May 2014
Total Debt
—
Q1 May 2014
Shares Outstanding
78.94M sh
Q1 May 2014
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.